Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Remote Monitoring for Equity in Advancing Control of Hypertension

NCT: NCT05481892 · COMPLETED

NCT IDNCT05481892
StatusCOMPLETED
Start Date2023-04-20
Completion2026-04-16

Brief Summary

The goal of this study is to support patients with hypertension self-management using both home blood pressure monitors and digital messaging programs. The investigators will first engage patients with technology training to use home monitors, online portal websites to view their medical record information online, and texting and mobile phone applications. Then investigators will assess the effectiveness of home blood pressure monitors and enhanced patient-clinician digital communication on blood pressure control during a 12-month intervention.

Frequently Asked Questions

What is Remote Monitoring for Equity in Advancing Control of Hypertension?

Remote Monitoring for Equity in Advancing Control of Hypertension is a clinical trial registered under NCT05481892. Current status: COMPLETED.

What is the status of NCT05481892?

The current status of NCT05481892 (Remote Monitoring for Equity in Advancing Control of Hypertension) is: COMPLETED.

When did Remote Monitoring for Equity in Advancing Control of Hypertension start?

Remote Monitoring for Equity in Advancing Control of Hypertension started on 2023-04-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.